Published in Reprod Sci on May 07, 2013
Old drug, new trick: repurposing metformin for gynecologic cancers? Gynecol Oncol (2014) 1.11
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models. Am J Obstet Gynecol (2014) 0.93
Clinical benefits of metformin in gynecologic oncology. Oncol Lett (2015) 0.91
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer (2015) 0.87
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women. Oncotarget (2015) 0.86
Diet quality and survival after ovarian cancer: results from the Women's Health Initiative. J Natl Cancer Inst (2014) 0.85
Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro. Exp Ther Med (2016) 0.81
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. Oncotarget (2015) 0.79
Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer. Biomed Res Int (2014) 0.79
Update on immune checkpoint inhibitors in gynecological cancers. J Gynecol Oncol (2016) 0.75
Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression. Oncotarget (2017) 0.75
New insight for metformin against bladder cancer. Genes Environ (2017) 0.75
Structural and functional identification of vasculogenic mimicry in vitro. Sci Rep (2017) 0.75
Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells. Am J Transl Res (2017) 0.75
IL-4 upregulates cyclooxygenase-1 expression in macrophages. J Biol Chem (2017) 0.75
Metformin and reduced risk of cancer in diabetic patients. BMJ (2005) 13.04
The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer (2009) 9.01
Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol (1989) 6.86
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res (2009) 6.74
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol (2001) 4.45
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res (2011) 2.93
Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res (1987) 2.67
Understanding the benefit of metformin use in cancer treatment. BMC Med (2011) 2.28
Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician (2009) 2.18
Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res (2012) 2.17
Metformin and cancer: new applications for an old drug. Med Oncol (2011) 2.03
Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia (2011) 2.00
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med (2011) 1.93
Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs (1995) 1.82
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep (2012) 1.66
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2006) 1.56
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol (2012) 1.29
Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol (2011) 1.27
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol (2001) 1.26
Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations. Clin Drug Investig (2011) 1.17
Pegylated liposomal doxorubicin in ovarian cancer. Int J Nanomedicine (2006) 1.13
Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer. Cancer Res (2010) 1.12
Metformin as an antitumor agent in cancer prevention and treatment. J Diabetes (2011) 1.03
Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res (2008) 1.01
Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer. Mol Cancer Ther (2008) 1.00
Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients. Cancer Chemother Pharmacol (1996) 0.99
Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach. J Thorac Oncol (2011) 0.93
TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract. Apoptosis (2007) 0.90
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer. Clin Pharmacol Ther (2007) 0.83
A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies. Br J Cancer (2005) 0.83
Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. Exp Clin Endocrinol Diabetes (2010) 0.83
Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study. Cytometry A (2003) 0.82
Cell cycle dependent antagonistic interactions between paclitaxel and carboplatin in combination therapy. Cancer Biol Ther (2007) 0.81
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. Endocr Relat Cancer (2007) 0.80
Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva. Eur J Clin Pharmacol (1983) 0.79
Effect of metformin on insulin sensitivity and insulin secretion in female obese patients with normal glucose tolerance. Diabetes Metab (2003) 0.77
Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res (2003) 1.87
Glucose transporters: expression, regulation and cancer. Biol Res (2002) 1.74
A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol Res (2009) 1.15
Intimate partner violence among Latinas in eastern North Carolina. Violence Against Women (2007) 1.08
Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol (2003) 1.04
Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells. Tissue Cell (2007) 1.02
Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1. J Clin Endocrinol Metab (2004) 1.02
Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. Endocrinology (2003) 0.93
Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer (2012) 0.92
TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract. Apoptosis (2007) 0.90
Iron-deficiency anemia is associated with altered characteristics of sleep spindles in NREM sleep in infancy. Neurochem Res (2007) 0.90
The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population. Anesth Analg (2013) 0.89
Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials (2013) 0.88
The action of ovarian hormones in cardiovascular disease. Biol Res (2003) 0.87
Extracting fuzzy rules from polysomnographic recordings for infant sleep classification. IEEE Trans Biomed Eng (2006) 0.86
Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. J Endocrinol (2012) 0.86
Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75. J Cell Physiol (2008) 0.85
Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. J Endocrinol (2004) 0.85
Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors. Epigenetics (2013) 0.85
11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension. Endocrine (2009) 0.84
Tissue factor is regulated by epidermal growth factor in normal and malignant human endometrial epithelial cells. Thromb Haemost (2005) 0.84
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem (2012) 0.84
Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia. Pediatr Infect Dis J (2012) 0.83
Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI. J Cell Physiol (2011) 0.82
Automated sleep-spindle detection in healthy children polysomnograms. IEEE Trans Biomed Eng (2010) 0.81
Increased urinary glucocorticoid metabolites are associated with metabolic syndrome, hypoadiponectinemia, insulin resistance and β cell dysfunction. Steroids (2011) 0.81
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. Endocr Relat Cancer (2007) 0.80
Mechanisms of paracrine regulation by fetal membranes of human uterine quiescence. J Soc Gynecol Investig (2006) 0.80
Automated detection of rapid eye movements in children. Conf Proc IEEE Eng Med Biol Soc (2012) 0.79
Independent anti-angiogenic capacities of coagulation factors X and Xa. J Cell Physiol (2014) 0.79
2-methoxyestradiol and disorders of female reproductive tissues. Horm Cancer (2014) 0.79
A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy. Biol Res (2015) 0.79
[In vitro cell response to chemotherapeutic agents, to personalize ovarian cancer treatment: report of two cases]. Rev Med Chil (2013) 0.78
Glucose transporters in sex steroid hormone related cancer. Curr Vasc Pharmacol (2009) 0.78
Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol (2009) 0.78
2-methoxyestradiol mediates apoptosis through caspase-dependent and independent mechanisms in ovarian cancer cells but not in normal counterparts. Reprod Sci (2008) 0.78
Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol Ther (2004) 0.78
Isoform α of PKC may contribute to the maintenance of pregnancy myometrial quiescence in humans. Reprod Sci (2012) 0.78
Brain natriuretic peptide (BNP) produced by the human chorioamnion may mediate pregnancy myometrial quiescence. Reprod Sci (2009) 0.78
[Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension]. Rev Med Chil (2008) 0.77
PPARα and PPARγ regulate the nucleoside transporter hENT1. Biochem Biophys Res Commun (2012) 0.77
Antiangiogenic, antimigratory and antiinflammatory effects of 2-methoxyestradiol in zebrafish larvae. Comp Biochem Physiol C Toxicol Pharmacol (2012) 0.77
2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Horm Cancer (2010) 0.76
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases. World J Surg Oncol (2013) 0.76
In vivo and in vitro estrogenic and progestagenic actions of Tibolone. Biol Res (2005) 0.75
Dual approach for automated sleep spindles detection within EEG background activity in infant polysomnograms. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
Mechanical stretch increases brain natriuretic peptide production and secretion in the human fetal membranes. Reprod Sci (2012) 0.75
Sleep-spindle identification on EEG signals from polysomnographie recordings using correntropy. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
[Molecular epidemiology of a streptococcus pyogenes related nosocomial outbreak in a burn unit]. Rev Med Chil (2003) 0.75
11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort. Am J Hypertens (2012) 0.75
Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine (2014) 0.75
Concanavalin-A induces granulosa cell death and inhibits FSH-mediated follicular growth and ovarian maturation in female rats. Endocrinology (2013) 0.75
[Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study]. Rev Med Chil (2016) 0.75
[Human papillomavirus testing in cervical cancer screening at a public health service of Santiago, Chile]. Rev Med Chil (2015) 0.75
Automated detection of apnea/hypopnea events in healthy children polysomnograms: preliminary results. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
Multi-objective optimization for personalized prediction of venous thromboembolism in ovarian cancer patients. IEEE J Biomed Health Inform (2019) 0.75
[Pelvic intravenous leiomyomatosis with intracardiac extension: report of two cases]. Rev Med Chil (2012) 0.75